Overexpression of BZW1 Is an Independent Poor Prognosis Marker and Its Down-Regulation Suppresses Lung Adenocarcinoma Metastasis

Scientific Reports - United Kingdom
doi 10.1038/s41598-019-50874-x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Overexpression of Geranylgeranyl Diphosphate Synthase Contributes to Tumour Metastasis and Correlates With Poor Prognosis of Lung Adenocarcinoma

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2018English

SKA3 Up-Regulation Promotes Lung Adenocarcinoma Growth and Is a Predictor of Poor Prognosis

Open Life Sciences
ImmunologyMolecular BiologyGeneticsBiochemistryMicrobiology Biological SciencesAgriculturalNeuroscience
2019English

Up-Regulation of CKAP2L Expression Promotes Lung Adenocarcinoma Invasion and Is Associated With Poor Prognosis

OncoTargets and Therapy
OncologyPharmacology
2019English

Overexpression of ANLN in Lung Adenocarcinoma Is Associated With Metastasis

Thoracic Cancer
MedicinePulmonaryRespiratory MedicineOncology
2019English

P2.09-32 Detached Epithelial Cell Cluster Size in Lung Adenocarcinoma Is a Marker of Poor Prognosis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

SIRT1 Expression Is Associated With Poor Prognosis of Lung Adenocarcinoma

OncoTargets and Therapy
OncologyPharmacology
2015English

Overexpression of RHEB Is Associated With Metastasis and Poor Prognosis in Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Epigenetically Regulated Chromosome 14q32 miRNA Cluster Induces Metastasis and Predicts Poor Prognosis in Lung Adenocarcinoma Patients

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2018English

RAD21 Cohesin Overexpression Is a Prognostic and Predictive Marker Exacerbating Poor Prognosis in KRAS Mutant Colorectal Carcinomas

British Journal of Cancer
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy